This will offer another alternative generic as if you read on the web there’s a lot of comments about how the generic doesn’t work as well and this is odd because they are both manufactured in the same Ortho-McNeil plant but we don’t know the formulation so again you would think they would be real close if for no other reason than extensive retooling the production line. Now here’s one from a totally different manufacturer. BD
Mallinckrodt, the Pharmaceuticals business of Covidien plc (COV - Analyst Report), has won the U.S. Food and Drug Administration (FDA)
approval to manufacture and sell a generic version of CONCERTA (methylphenidate HCl) Extended-Release (ER) Tablets USP (CII) in 27 mg, 36 mg and 54 mg dosage strengths. The tablets are used to treat patients, aged between 6 and 65, suffering from Attention Deficit Hyperactivity Disorder (ADHD). ADHD is a neurobehavioral disorder, usually diagnosed in childhood.
Children with ADHD are inattentive, hyperactive and impulsive. Despite being a long-term chronic condition, it can be successfully treated with proper therapy and medication.
http://www.zacks.com/stock/news/89503/fda-approves-covidien-drug
No comments:
Post a Comment